Researchers target silicon chips for biomolecular devices

Arizona State University researchers in the Ira A. Fulton School of Engineering are key contributors to an $11.7 million, multicollaborative Defense Advanced Research Project Agency research project developing novel hybrid biomolecular nanodevices and systems for potential application as biosensors in areas such as disease detection, pharmaceutical drug-testing, drug-delivery systems and health monitoring.

Hybrid biomolecular devices involve interfacing biological matter with electronic circuitry to create a silicon chip that can interpret and convert molecular changes into real-time digital information.

Stephen Goodnick, a professor of electrical engineering, and Trevor Thornton, also a professor of electrical engineering and director of the Center for Solid State Electronics at ASU, are leading the university’s efforts.

The multi-institutional grant, part of the Engineered Bio-Molecular Nano-Devices/Systems (MOLDICE) Program within DARPA’ s Defense Sciences Office, involves researchers from Rush Medical Hospital in Chicago and six other partner universities: UCLA, Texas A&M, the University of Florida, the University of Utah, Rush Medical, Oxford University and the Max Planck Polymer Institute in Mainz, Germany. ASU’s share in the grant is $1.7 million, which is one of the largest portions.

The DARPA grant is being conducted in two phases. Phase I, completed recently, has yielded significant results from the ASU side, Goodnick says.

Goodnick and Thornton have integrated an artificial cell membrane into a silicon chip. The chip contains integrated electrodes that measure the ion current flowing in solution from one side of the membrane to the other, through a single protein channel inserted into the membrane.

Quantifying sodium and potassium ion transport properties and structure in a cell wall is of particular importance, because it helps in identifying protein structure, including mutations that can affect the cell’s function.

The pharmaceutical industry is especially interested in this type of process, because channel proteins are noted for their unique ability to react to different types of drugs. Biomolecular devices can help provide valuable electrophysiological feedback that warns researchers of potential side effects of new drugs that are being tested.

The ion channel measurements, demonstrated by Goodnick and Thornton, represent the first such measurements performed in a silicon platform.

“Potential applications include use of this structure as a biosensor, where ion-channel proteins bind to specific target biological agents, hence changing the electrical behavior of the channel,” Goodnick says.

This was the primary application funded by DARPA, he adds.

Other applications include traditional uses of ion-channel measurements in drug testing, where ion channels and the patch clamp measurement technique are used to study the response of channels that are targeted by specific drugs, such as those regulating the heart. The patch clamp measurement requires a number of complex instruments and is a traditional laboratory-scale technique used for measuring ionic currents through channels.

“Effectively, we have demonstrated that we can perform patch clamp measurements on a chip, leading to the possibility of lower noise and substantial reduction in size for a portable device,” Goodnick says.

As with any new process, one of the biggest hurdles that researchers faced was the interface between the biological and non-biological world.

“Processes compatible with semiconductor processing are not generally amenable to biological systems,” he says.

In particular, getting a lipid bilayer (the component of cell walls) to adhere to a substrate required a special process that was developed at ASU. This process helped to make the chip surface hydrophobic, or water repellent, to attach the bilayer.

Phase II, which will integrate ASU’s work with the research of other partners, will involve prototyping a complete system in the form of a handheld ion-channel biosensor that can be tested in a microfluidic array system.

Goodnick believes that biomolecular devices essentially are fueling much of the research being conducted in the information technology arena today.

“Such devices are expected to appear increasingly in health-monitoring applications, where implanted bionano devices monitor drug delivery and predict epileptic or heart attacks, while transmitting information externally or taking remedial actions to prevent such attacks,” he says. “Bionanoelectronics also hold the potential for new types of electronic devices for computing and information processing based on biological principles.”

Thornton explains the usefulness of this type of sensor in the context of the recent controversy surrounding the recall of Vioxx, a prescription painkiller developed by Merck Pharmaceuticals.

“Despite stringent FDA testing, when Vioxx was finally released on the market, it caused fatal heart attacks in a small percentage of the population,” he says. “The reason for this was that Vioxx interfered with the ion channel proteins that controlled the beating of the heart. As a result of this, all new medications have to be screened against such interactions with ion channel proteins. Currently, this screening is done in a very laborious manner. Our chip promises to help automate the process.”

Source: ASU

Related stories:

The next generation: nanomagnets could replace semiconductors
Just as compact discs all but wiped out vinyl records, semiconductors could be on their way out, too. A University of Houston professor has developed a similar ‘disruptive technology,’ using magnetic cellular networks, that could yield such benefits as increased computing power that rivals what is possible with semiconductor integrated circuits.
Researchers Look to Nature for Design Inspiration
Georgia Tech researchers studying nature’s masterful and time-tested design techniques to find answers for some of science’s toughest design challenges presented their research May 11 and May 12 at the International Symposium for Biologically-inspired Design and Engineering at Georgia Tech.
Researchers make long DNA 'nanowires' for future medical and electronic devices
Ohio State University researchers have invented a process for uncoiling long strands of DNA and forming them into precise patterns. Ultimately, these DNA strands could act as wires in biologically based electronics and medical devices, said L. James Lee, professor of chemical and biomolecular engineering at Ohio State University.
Researchers create first nanofluidic transistor
University of California, Berkeley, researchers have invented a variation on the standard electronic transistor, creating the first "nanofluidic" transistor that allows them to control the movement of ions through sub-microscopic, water-filled channels.
Researchers Construct Tiny, Floating 'Eyeballs,' 'Billiard Balls' on Microchip
North Carolina State University chemical engineers have discovered a way to construct new microscopic devices that can act like tiny factories for materials with potential for a wide variety of chemical and biological uses.
The NC State researchers, advised by Dr. Orlin Velev, assistant professor of chemical and biomolecular engineering, include undergraduate student Jeffrey R. Millman and graduate students Ketan H. Bhatt and Brian G. Prevo. They created different types of tiny particles that could eventually be used in everything from drug delivery to determinations of the presence or concentration of biological molecules.
Nanomaterials break out of laboratory into marketplace
Miniature medical machines that can bring sight to the blind and computers that work at the speed of light are no longer the stuff of futuristic novels. Argonne National Laboratory researchers are creating nanomaterials and nanotechnology to make these and other innovations possible, and collaborating with industry to bring new technologies to the marketplace.
New surface chemistry may extend life of technology for making transistors
Researchers at the University of Illinois at Urbana-Champaign have developed a technique that uses surface chemistry to make tinier and more effective p-n junctions in silicon-based semiconductors. The method could permit the semiconductor industry to significantly extend the life of current ion-implantation technology for making transistors, thereby avoiding the implementation of difficult and costly alternatives.
To make faster silicon-based transistors, scientists much shrink the active region in p-n junctions while increasing the concentration of electrically active dopant. Currently about 25 nanometers thick, these active regions must decrease to about 10 nanometers, or roughly 40 atoms deep, for next-generation devices.
Philips demonstrates magnetic biosensors for high-sensitivity molecular diagnostics
Scientists at Philips Research are investigating a new magnetic biosensor technology that promises to radically improve the speed, sensitivity and reliability of biomolecular diagnostics for applications such as protein and pathogen monitoring, near-patient testing in medical centers (blood, urine, saliva tests etc.), and ultimately home testing by individuals. Philips' biosensor measures the magnetic field created by magnetic nano-particles that bind to target molecules in a biological assay. Compared to optical sensing methods, the use of magnetic nano-particles not only eliminates the additional steps required to bind optical labels to the target molecules. It also promises biosensors that are up to one hundred times more sensitive than existing devices.

News discussion:

Nanotechnology news